Apollon Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
96,041
+3,301
+4% +$386K 0.15% 133
2026
Q1
$11.2M Buy
92,740
+2,665
+3% +$308K 0.18% 116
2025
Q4
$9.48M Buy
90,075
+791
+0.9% +$74.3K 0.16% 120
2025
Q3
$7.49M Sell
89,284
-1,203
-1% -$99.1K 0.13% 146
2025
Q2
$7.16M Sell
90,487
-2,160
-2% -$172K 0.14% 138
2025
Q1
$8.32M Sell
92,647
-5,068
-5% -$473K 0.18% 112
2024
Q4
$9.72M Sell
97,715
-1,574
-2% -$162K 0.22% 83
2024
Q3
$11.3M Sell
99,289
-5,538
-5% -$658K 0.32% 62
2024
Q2
$13M Buy
104,827
+3,625
+4% +$467K 0.4% 49
2024
Q1
$13.4M Buy
101,202
+2,787
+3% +$344K 0.42% 48
2023
Q4
$10.7M Buy
98,415
+22,991
+30% +$2.39M 0.37% 52
2023
Q3
$7.76M Buy
75,424
+437
+0.6% +$47.1K 0.39% 54
2023
Q2
$8.65M Buy
74,987
+252
+0.3% +$28.6K 0.42% 46
2023
Q1
$7.95M Buy
74,735
+3,041
+4% +$328K 0.49% 37
2022
Q4
$7.95M Buy
71,694
+9,195
+15% +$940K 0.56% 27
2022
Q3
$5.38M Buy
62,499
+2,585
+4% +$231K 0.44% 42
2022
Q2
$5.46M Buy
59,914
+595
+1% +$52.7K 0.45% 38
2022
Q1
$4.87M Sell
59,319
-1,530
-3% -$121K 0.35% 58
2021
Q4
$4.66M Buy
60,849
+21,613
+55% +$1.72M 0.35% 59
2021
Q3
$2.95M Buy
39,236
+20,738
+112% +$1.58M 0.4% 46
2021
Q2
$1.44M Sell
18,498
-1,824
-9% -$136K 0.26% 76
2021
Q1
$1.5M Buy
20,322
+14,839
+271% +$1.09M 0.29% 69
2020
Q4
$428K Sell
5,483
-5,110
-48% -$391K 0.12% 132
2020
Q3
$838K Buy
10,593
+3,025
+40% +$237K 0.38% 66
2020
Q2
$558K Buy
7,568
+3,237
+75% +$244K 0.31% 51
2020
Q1
$318K Sell
4,331
-157
-3% -$12.3K 0.33% 43
2019
Q4
$383K Sell
4,488
-70
-2% -$5.75K 0.34% 42
2019
Q3
$366K Sell
4,558
-378
-8% -$30.3K 0.38% 41
2019
Q2
$395K Buy
4,936
+80
+2% +$6.13K 0.45% 33
2019
Q1
$385K Sell
4,856
-84
-2% -$6.28K 0.51% 34
2018
Q4
$351K Buy
+4,940
New +$349K 0.32% 34

Other funds holding MRK

Apollon Wealth Management's MRK Position: Q2 2026 in Review

Apollon Wealth Management increased its Merck (MRK) stake by 3.6% in Q2 2026, buying an estimated $386K and bringing the position to 96,041 shares worth $12.3M. The position accounts for 0.15% of the portfolio, ranked #133.

Apollon Wealth Management first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $13.4M in Q1 2024. 1,166 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Apollon Wealth Management held 96,041 shares of Merck worth $12.3M as of Q2 2026.
  • Apollon Wealth Management bought 3,301 Merck shares in Q2 2026, an estimated $386K.
  • Merck made up 0.15% of Apollon Wealth Management's portfolio in Q2 2026, its #133 holding.
  • Apollon Wealth Management first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
  • Apollon Wealth Management's Merck position peaked at $13.4M in Q1 2024.
  • 1,166 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.